Status of Diabetic Neuropathy in Korea: A National Health Insurance Service-National Sample Cohort Analysis (2006 to 2015)
- Author:
Seong-Su MOON
1
;
Chong Hwa KIM
;
Seon Mee KANG
;
Eun Sook KIM
;
Tae Jung OH
;
Jae-Seung YUN
;
Ho Chan CHO
;
Dae Jung KIM
;
Tae Sun PARK
Author Information
- Publication Type:Brief Report
- From:Diabetes & Metabolism Journal 2021;45(1):115-119
- CountryRepublic of Korea
- Language:English
- Abstract: This report presents the status of diabetic neuropathy (DN) in Korea as determined using a National Health Insurance ServiceNational Sample Cohort (NHIS-NSC). Annual prevalences of DN were estimated by age and gender using descriptive statistics. Pharmacological treatments for DN were also analyzed. The annual prevalence of DN increased from 24.9% in 2006 to 26.6% in 2007, and thereafter, gradually subsided to 20.8% in 2015. In most cases, pharmacological treatments involved a single drug, which accounted for 91.6% of total prescriptions in 2015. The most commonly used drugs (in decreasing order) were thioctic acid, an anti-convulsive agent, or a tricyclic antidepressant. In conclusion, the prevalence of DN decreased over the 10-year study period. Thioctic acid monotherapy was usually prescribed for DN. To reduce the socio-economic burden of DN, more attention should be paid to the diagnosis of this condition and to the appropriate management of patients.
